| |
KOMISJA NADZORU FINANSOWEGO |
|
| |
|
|
Raport bieżący nr |
3 |
/ |
2022 |
|
|
|
| |
Data sporządzenia: |
2022-04-11 |
|
|
|
|
|
|
|
|
|
| |
Skrócona nazwa emitenta |
|
|
|
|
|
|
|
|
|
| |
MILESTONE MEDICAL |
|
| |
Temat |
|
|
|
|
|
|
|
|
|
|
| |
Commencing Sales of CompuFlo Epidural / CathCheck Verification System Disposables
to a Premier Northeast Hospital in the U.S.
|
|
| |
Podstawa prawna |
|
|
|
|
|
|
|
|
| |
Art. 17 ust. 1 MAR - informacje poufne.
|
|
| |
Treść raportu: |
|
|
|
|
|
|
|
|
|
| |
The Board of Directors of Milestone Medical Inc. _WAR: MMD, "the Company", "the Issuer"_,
today announced that it has commenced sales of its CompuFlo Epidural and CathCheck
Verification System disposables to a leading northeast medical center in the U.S.
The name of the hospital cannot be disclosed for confidentiality reasons.
The Board of Directors of the Company is pleased to announce adoption of our CompuFlo
Epidural and CathCheck Verification System by another leading medical center. This
approval follows an extensive trial and evaluation, which validates the safety and
efficacy of the technology. As a teaching hospital, the Company's tools provide residents,
fellows and seasoned physicians greater accuracy through real-time verification of
epidural needle placement, as well as subsequent monitoring of catheter placement.
With the addition of this hospital the Company continues to expand the national footprint
in the labor and delivery market.
|
|
|
RB_ASO: Commencing Sales of CompuFlo Epidural / CathCheck Verification System Disposables
to a Premier Northeast Hospital in the U.S.
